IPAB quashes revocation of Novartis patent for anti-cancer drug Ceritinib

Natco filed a post-grant opposition against the patent on September 26, 2017, on grounds of obviousness and lack of inventive step.

from Lifestyle News:Entertainment News,Bollywood Latest News,Box Office Collection Report,Movie Reviews
Read The Rest:financialexpress...